Compound Details
OXYDROL tablets contain Oxymetholone USP (CAS 434-07-1). Pharmaceutical-grade anabolic compound by NovaTech Sciences supporting muscle growth, performance, and hormone balance.
Form
Oral tablets
Strength
50 mg Oxymetholone per tablet
Packaging
Bottle of 100 tablets
Tablet Type
Pharmaceutical-grade anabolic steroid
Usage Category
Muscle growth, strength, recovery, bulking
Suitable For
Athletes, bodybuilders, therapeutic muscle support
OXYDROL Tablets by NovaTech Sciences contain pharmaceutical-grade Oxymetholone USP (CAS 434-07-1), an orally active anabolic compound known for its strong association with muscle growth, performance environments, and hormone balance support. Oxymetholone is globally identified through CAS 434-07-1, ensuring compound authenticity, chemical traceability, and pharmaceutical standardization across international healthcare and pharmaceutical markets.
NovaTech Sciences manufactures Oxymetholone CAS 434-07-1 using strict pharmaceutical quality protocols designed to maintain compound purity, formulation accuracy, and consistent global supply.
Oxymetholone, registered under CAS 434-07-1, is an orally active anabolic compound derived from dihydrotestosterone (DHT). It is widely recognized in pharmaceutical contexts for its strong anabolic activity and its historical use in certain medical therapies related to red blood cell production and tissue preservation.
The CAS registry number 434-07-1 serves as the internationally recognized chemical identifier for Oxymetholone USP. This identifier ensures compound verification, regulatory transparency, and consistent identification across pharmaceutical manufacturing and distribution systems.
Oxymetholone USP (CAS 434-07-1) interacts with androgen receptors within the body. These receptors influence several physiological processes related to muscle growth, protein synthesis, and tissue development.
Oxymetholone is known for its strong anabolic characteristics and its influence on cellular growth pathways linked to tissue development.
Each batch of Oxymetholone CAS 434-07-1 undergoes comprehensive laboratory testing to confirm compound identity, purity verification, and formulation consistency.
NovaTech Sciences operates as a trusted manufacturer, supplier, and exporter of pharmaceutical-grade anabolic compounds for global markets. By specifying CAS 434-07-1, OXYDROL tablets maintain chemical authenticity and regulatory transparency.
These strict quality processes ensure Oxymetholone USP tablets meet international pharmaceutical distribution standards.
NovaTech Sciences prioritizes pharmaceutical precision, regulatory compliance, and compound reliability. OXYDROL tablets containing Oxymetholone CAS 434-07-1 are produced using advanced pharmaceutical technologies designed to maintain stable formulations and consistent product quality.
For pharmaceutical distributors and professional markets seeking a reliable source of Oxymetholone USP (CAS 434-07-1), OXYDROL Tablets by NovaTech Sciences provide verified compound identity, pharmaceutical manufacturing excellence, and dependable global supply. Supported by strict quality assurance protocols, Oxymetholone CAS 434-07-1 remains a recognized anabolic compound associated with muscle development, performance environments, and hormone balance applications.
Precautions
Contraindications
Oxymetholone is a synthetic anabolic-androgenic steroid identified by CAS Number 434-07-1. It has the molecular formula C21H32O3 and is structurally related to testosterone. Nova Techsciences associates this compound with its OXYDROL tablet range; however, any product strength, indication or supply claim should match verified packaging and applicable regulatory documentation.
This compound page provides general chemical, quality and safety information. It should not replace authorised prescribing information, a patient information leaflet or assessment by a qualified healthcare professional.
The CAS number is an internationally recognised identifier that distinguishes Oxymetholone from Oxandrolone, Methandienone, Stanozolol and other compounds with similar-sounding names. The correct compound name and identifier should remain consistent across product pages, labels, structured data, Certificates of Analysis and batch records.
A responsible Oxymetholone compound profile should be supported by current analytical documentation. Suitable controls may include raw-material identification, active-compound assay, impurity analysis, reference-standard comparison, tablet content uniformity, dissolution assessment, stability testing and packaging-integrity verification.
Each manufactured batch should carry a unique identification number connected to its production history and laboratory-release results. Statements involving purity, pharmaceutical grade, laboratory testing or manufacturing compliance should only be published when supporting evidence is available.
For audiences in the United Kingdom, Netherlands and other European markets, Nova Techsciences should clearly state the compound’s marketing-authorisation status, legal supply classification, responsible organisation and adverse-event reporting procedure.
Oxymetholone is not an ordinary dietary or wellness ingredient. The NIH LiverTox database includes it among anabolic steroids associated with clinically important liver injury. Compounds in this class have been linked to cholestasis, vascular liver abnormalities and liver tumours. The US National Toxicology Program also reports evidence concerning oxymetholone and liver-tumour risk.
Oxymetholone should not be presented for self-medication, bodybuilding, athletic performance or use by minors. Information about doses, cycles, combinations or methods intended to manage side effects should not be taken from unofficial online sources.
MK-677, also known as Ibutamoren Mesylate, is a non-peptide growth-hormone secretagogue rather than an anabolic steroid. It is chemically distinct from Oxymetholone and requires separate information covering its investigational status, clinical evidence, metabolic safety considerations and regulatory position.
Methandienone is an orally active anabolic-androgenic steroid identified by CAS Number 72-63-9. It has a separate chemical structure and risk profile from Oxymetholone. Its compound information should independently address liver, cardiovascular, hormonal and reproductive safety concerns.
Clenbuterol Hydrochloride is a beta-adrenergic agonist identified by CAS Number 21898-19-1. It is pharmacologically different from anabolic steroids and may affect cardiovascular and nervous-system function. Its legal and authorised status varies between markets and should be stated accurately.
Stanozolol is an anabolic-androgenic steroid identified by CAS Number 10418-03-8. It is chemically distinct from Oxymetholone, although both belong to the anabolic-steroid category. Its page should provide independent chemical identification, batch documentation and prominent liver and cardiovascular safety information.
STANOVA-50 represents a higher-strength Stanozolol presentation rather than a different active compound. The page should clearly distinguish product strength while retaining the same CAS Number 10418-03-8, alongside appropriate contraindications, regulatory status and batch traceability.
Oxymetholone should ultimately be presented through accurate compound identification, transparent analytical documentation, balanced safety communication and clearly stated regulatory limitations.
Premium aromatase inhibitor tablets for estrogen suppression and effective hormone balance support.
Buy Tamoxifen Citrate (CAS 54965-24-1) by NovaTech Sciences. Premium tablets for estrogen modulation, hormone support, and targeted receptor activity.
Buy Anastrozole (CAS 120511-73-1) by NovaTech Sciences. Pharmaceutical-grade aromatase inhibitor tablets for estrogen suppression and hormone regulation.
